Abstract
Abstract. Guar gum has been used in the management of hypercholesterolemia, constipation, weight loss, type 2 diabetes mellitus and hypertension. Our aim was to verify the hypothesis that Guar gum can be used as an alternative to pharmacological agents in the treatment of mild hypertension. Thus, we conducted a systematic review and meta-analysis to evaluate the effectiveness of Guar gum in reducing blood pressure. We searched the Cochrane Library, PubMed/Medline, Scopus and Google Scholar databases for studies published in the English language up to June 2020 which evaluated the effects of gum consumption on systolic blood pressure (SBP) and diastolic blood pressure (DBP). Nine randomized clinical trials with suitable comparison groups (placebo/control) reported SBP and DBP as outcome measures. These trials involved in total 640 participants. The overall results indicated that the consumption of gum resulted in a significant change in SBP (WMD: −1.190 mmHg, 95% CI: −2.011, −0.370) and DBP (WMD: −1.101 mmHg, 95% CI: −1.597, −0.605). Moreover, the greatest reduction in blood pressure was seen in patients with type 2 diabetes mellitus and metabolic syndrome who consumed Guar gum (WMD: −3.375 mmHg). In addition, there was a significant decrease in SBP if the gum dosage was > 15 g (WMD: −6.637 mmHg) and if the intervention duration was > 12 weeks (WMD: −1.668 mmHg). The results of the present dose-response meta-analysis support the employment of gum consumption in the reduction of SBP and DBP. Based on the sub-group analyses, we highlight that the greatest decrease in SBP was experienced if the gum dosage was > 15 g and when the intervention lasted > 12 weeks.
References
1 An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension. 2014;63(4):878–85.
2 Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA. 2017;317(2):165–82.
3 Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017;390(10100):1345–422.
4 May Measurement Month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health. 2018;6(7):e736–e43.
5 . Hypertension [Internet]. Geneva: World Health Organization; 2019. Available from https://www.who.int/news-room/fact-sheets/detail/hypertension
6 Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94(3):567–81.
7 . Dyslipidemia: A trigger for coronary heart disease in Romanian patients with diabetes. Metabolites. 2020;10(5):195.
8 Low-density lipoprotein cholesterol lowering treatment: the current approach. Lipids Health Dis. 2020;19(1):85.
9 May measurement month 2019: The global blood pressure screening campaign of the International Society of Hypertension. Hypertension. 2020;76(2):333–41.
10 Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19 1 million participants. Lancet. 2017;389(10064):37–55.
11 . Global action plan for the prevention and control of noncommunicable diseases 2013–2020 [Internet]. Geneva: World Health Organization; 2013. Available from https://www.who.int/publications/i/item/9789241506236
12 Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA. 2015;314(12):1255–63.
13 The long-term effects of lifestyle change on blood pressure: One-year follow-up of the ENCORE study. Am J Hypertens. 2014;27(5):734–41.
14 The multiple lifestyle modification for patients with prehypertension and hypertension patients: a systematic review protocol. BMJ Open. 2014;4(8):e004920.
15 Effects of folic acid supplementation on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials. NMCD. 2019;29(5):432–9.
16 The effect of Aronia consumption on lipid profile, blood pressure, and biomarkers of inflammation: A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2019;33(8):1981–90.
17 The effect of green coffee extract supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2019;33(11):2918–26.
18 . Effects of intermittent fasting and energy-restricted diets on lipid profile: A systematic review and meta-analysis. Nutrition. 2020;77:110801.
19 The influence of fasting and energy restricting diets on blood pressure in humans: a systematic review and meta-analysis. High Blood Press Cardiovasc Prev. 2020;27(4):271–80.
20 The effects of astaxanthin supplementation on obesity, blood pressure, CRP, glycemic biomarkers, and lipid profile: A meta-analysis of randomized controlled trials. Pharmacol Res. 2020;161:105113.
21 The influence of fasting and energy-restricted diets on leptin and adiponectin levels in humans: A systematic review and meta-analysis. Clin Nutr. 2020;SO261-5614(20)30577-X.
22 Guar gum reduces postprandial hypotension in older people. J Am Geriatr Soc. 2001;49(2):162–7.
23 The effect of gum consumption on anthropometric characteristics and cardiac disorders: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med. 2020;54:102578.
24 . The effect of oral glucose, protein, fat and water loading on blood pressure and the gastrointestinal peptides VIP and somatostatin in hypertensive elderly subjects. Eur J Clin Invest. 1990;20:192–8.
25 Guar gum and its composites as potential materials for diverse applications: A review. Carbohydr Polym. 2018;199:534–45.
26 . Antihypertensive Drugs. Side Effects of Drugs Annual. Amsterdam: Elsevier; 2014. p. 279–87.
27 . Drug side effect symptoms and adherence to antihypertensive medication. Am J Hypertens. 2016;29(6):772–9.
28 . Effects of guar gum ingestion on postprandial blood pressure in older adults. J Nutr Health Aging. 2015;19(3):299–304.
29 . Guar gum as a promising starting material for diverse applications: A review. Int J Biol Macromol. 2016;88:361–72.
30 . Effect of guar gum on the arterial blood pressure. Acta medica Scandinavica. 1987;222(1):43–9.
31 The effect of viscous soluble fiber on blood pressure: A systematic review and meta-analysis of randomized controlled trials. NMCD. 2018;28(1):3–13.
32 . Reprint – preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther. 2009;89(9):873–80.
33 . Cochrane handbook for systematic reviews of interventions version. 2011;5.
34 . Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):13.
35 . Local polynomial modelling and its applications: monographs on statistics and applied probability. London: Routledge; 2018.
36 . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
37 . Effect of Gum Arabic (Acacia Senegal) supplementation on visceral adiposity index (VAI) and blood pressure in patients with type 2 diabetes mellitus as indicators of cardiovascular disease (CVD): a randomized and placebo-controlled clinical trial. Lipids Health Dis. 2018;17(1):56.
38 Improvement of the metabolic syndrome profile by soluble fibre – guar gum – in patients with type 2 diabetes: a randomised clinical trial. Br J Nutr. 2013;110(9):1601–10.
39 . Psyllium improves dyslipidaemia, hyperglycaemia and hypertension, while guar gum reduces body weight more rapidly in patients affected by metabolic syndrome following an AHA Step 2 diet. Med J Nutrition Metab. 2010;3(1):47–54.
40 . Effect of flaxseed gum on reduction of blood glucose and cholesterol in type 2 diabetic patients. Int J Food Sci Nutr. 2009;60(Suppl 6):126–36.
41 . Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial. Clin Exp Hypertens. 2007;29(6):383–94.
42 . Hypolipidemic and antioxidant effects of commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther. 1994;8(4):659–64.
43 Endocrine and metabolic effects of guar gum in menopausal women. Gynecol Endocrinol. 1993;7(2):135–41.
44 . Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men. Am J Clin Nutr. 1992;56(6):1061–5.
45 . Guar gum and gemfibrozil – an effective combination in the treatment of hypercholesterolaemia. Atherosclerosis. 1989;76(1):71–7.
46 . Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47(2):296–308.
47 . Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med. 2005;165(2):150–6.
48 . Blood-pressure-lowering effect of a vegetarian diet: controlled trial in normotensive subjects. The Lancet. 1983;321(8314–8315):5–10.
49 . Treatment of type IIa hyperlipidemia in childhood by a simplified American Heart Association diet and fiber supplementation. Am J Dis Child. 1990;144(9):973–6.
50 . Essentials of human nutrition. Oxford: University Press; 2017.
51 . Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses. PLoS Med. 2020;17(3):e1003053.
52 . Comparison of two calorie-reduced diets of different carbohydrate and fiber contents and a simple dietary advice aimed to modify carbohydrate intake on glycemic control and inflammatory markers in type 2 diabetes: a randomized trial. Int J Endocrinol Metab. 2018;16(1):e12089.
53 . Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation. 2004;109(4):551–6.
54 . Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens. 2005;23(3):475–81.
55 A clinical trial of the effects of dietary patterns on blood pressure. New Engl J Med. 1997;336(16):1117–24.
56 . The unresolved role of dietary fibers on mineral absorption. Crit Rev Food Sci Nutr. 2017;57(5):949–57.
57 . Association of Dietary Fiber to Food Components. Science and Technology of Fibers in Food Systems. Berlin: Springer; 2020. p. 45–70.
58 . The UKPDS and its global impact. Diabet Med. 2008;25:57–62.
59 . CRC handbook of dietary fiber in human nutrition. Boca Raton: CRC; 2001.
60 . The role of carbohydrates in insulin resistance. J Nutr. 2001;131(10):2782S–6S.
61 . Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens. 2001;19(3):523–8.
62 . Evaluation of oxidative stress levels in obesity and diabetes by the free oxygen radical test and free oxygen radical defence assays and correlations with anthropometric and laboratory parameters. World J Diabetes. 2020;11(5):193–201.
63 . Polypharmacy in type 2 diabetes mellitus: insights from an internal medicine department. Medicina (Kaunas). 2019;55(8):436.
64 . Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease. Clin Exp Pharmacol Physiol. 1998;25(3–4):175–84.
65 . Viscous versus nonviscous soluble fiber supplements: Mechanisms and evidence for fiber-specific health benefits. J Am Acad Nurse Pract. 2012;24(8):476–87.
66 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1–e76.
